Muchas personas mayores aceptan las vacunas con entusiasmo. La investigación les da la razón
Kim Beckham, agente de seguros en Victoria, Texas, había visto a sus amigos sufrir tanto…
Muchas personas mayores aceptan las vacunas con entusiasmo. La investigación les da la razón
Kim Beckham, agente de seguros en Victoria, Texas, había visto a sus amigos sufrir tanto por la culebrilla (shingles) que quería recibir la primera vacuna aprobada contra esta infección tan pronto como estuviera disponible, incluso si tenía que pagarla de su bolsillo. Su médico y varias farmacias le dijeron que no podían administrarle la vacuna…
Vertex Pharma’s Type 1 Diabetes Cell Therapy Shows Potential to Achieve Insulin Independence
In Phase 1/2 results for 12 patients at least one year after receiving the cell therapy, zimislecel, Vertex Pharmaceuticals reported all participants achieved blood glucose in the target range and 10 of the 12 were free of exogenous insulin as of the data cutoff. Vertex expects to complete enrollment in the pivotal portion of the…
Cost impact of BTKi selection in Medicare patients with CLL
That is the title of my paper out today in the Journal of Comparative Effectiveness Research written with co-authors Adam Kittai, Dipen Patel, Nadine Zawadzki, Vikram Shetty, Yazan Barqawi, and Joanna Rhodes. The abstract is below. Aim: To estimate cost savings associated with covalent Bruton’s tyrosine kinase inhibitor (cBTKi) choice in patients with treatment-naive (TN) and…
Seven Million People with Medicare Spend More Than 10% of Income on Part B Premiums – The Reconciliation Bill Could Drive the Number Higher
People with low incomes and limited financial resources can qualify for the Medicare Savings Programs, through which state Medicaid programs provide financial assistance with Medicare premiums and cost sharing. However, provisions in the GOP’s budget reconciliation bill would make it harder for people to enroll in these programs. Many people with Medicare are facing a…
Pending Changes to Marketplace Plans Could Increase Cost-Sharing for Consumers
This brief looks at changes to Marketplace plans recently finalized by the Centers for Medicare and Medicaid Services (CMS) that may incentivize insurers to make their plans less generous. With less generous plans, consumers could face higher out-of-pocket costs, though those who don’t qualify for premium tax credits could see lower premiums.
Implications of Medicaid Work and Reporting Requirements for Adults with Mental Health or Substance Use Disorders
This brief describes key challenges that Medicaid work requirements may pose for adults with mental health or substance use disorders. In May, the House passed a budget reconciliation bill that includes national Medicaid work requirements for adults in the Affordable Care Act (ACA) expansion group.
What Privacy and Protection Standards are in Place for Medicaid Enrollees’ Personal Data?
This policy watch discusses the data privacy protections in Medicaid and the implications of breaches or violations of those protections.
The Overlooked Global Warming Cost We Can’t Ignore
Climate change not only impacts patients with respiratory allergies, but it also has potential broad and emerging impacts on patients with food allergies and overall public health. The post The Overlooked Global Warming Cost We Can’t Ignore appeared first on MedCity News.
The Medicaid Reckoning: Era of Fiscal and Policy Flux
The resilience of Medicaid lies in its complexity. It has resisted large-scale restructuring because it is interwoven with public and private delivery systems. That same complexity now demands a different kind of legal engagement. Medicaid is no longer a silo, but a system-defining platform. The post The Medicaid Reckoning: Era of Fiscal and Policy Flux…
Many Older People Embrace Vaccines. Research Is Proving Them Right.
Kim Beckham, an insurance agent in Victoria, Texas, had seen friends suffer so badly from shingles that she wanted to receive the first approved shingles vaccine as soon as it became available, even if she had to pay for it out-of-pocket. Her doctor and several pharmacies turned her down because she was below the recommended…
